Vericel Corp. (VCEL) Stock Price Down 3.2%
Vericel Corp. (NASDAQ:VCEL) shares traded down 3.2% during mid-day trading on Thursday . The company traded as low as $2.45 and last traded at $2.45, with a volume of 64,194 shares trading hands. The stock had previously closed at $2.53.
The stock’s 50-day moving average price is $2.21 and its 200 day moving average price is $2.79. The company’s market cap is $48.23 million.
Vericel Corp. (NASDAQ:VCEL) last released its earnings results on Monday, August 8th. The company reported ($0.21) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.16) by $0.05. The company had revenue of $12.80 million for the quarter, compared to the consensus estimate of $15.05 million. Equities analysts anticipate that Vericel Corp. will post ($0.91) EPS for the current fiscal year.
Vericel Corporation, formerly Aastrom Biosciences, Inc, is a commercial-stage biopharmaceutical company dedicated to the identification, development and commercialization of therapies that enable the body to repair and regenerate damaged tissues and organs to restore normal structure and function. The Company operates through the research, product development, manufacture and distribution of patient-specific, expanded cellular therapies for use in the treatment of specific diseases segment.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.